Prasugrel vs. Ticagrelor on Myocardial Injury in STEMI

Summary

The investigators propose to perform a randomized clinical trial comparing prasugrel vs. ticagrelor in 60 patients with ST elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. The principal objective of the study would be analyzing the difference in myocardial infarction size measured by cardiac magnetic resonance at 6 months

Timeline

Start

2015-11-23

Primary completion

2018-10-30

Completion

2018-12-31

Drugs

Indications